Recognizing the Shortcomings in Life Sciences SaaS CRM in 2017

SaaS CRM vendors are creating runaway recurring costs and exit barriers for life science companies in 2017

The CRM market in life sciences is dominated by a few specialized vertical-focused vendors whose solutions re¬flect an increasingly obsolete monolithic enterprise architecture that does not align with the macro trends, driving new decision-making priorities in life sciences.


As the life science industry evolves into 2020, new technology, stakeholders, and economic (macro) trends are limiting the effectiveness of the existing CRMs for profitable and sustainable growth. Meanwhile, vendors continue to innovate new SaaS products that only grow recurring fees and force technology parity across the life science industry.


This whitepaper outlines the significant macro trends impacting life science in 2017, and contrast those with the current limitations of major CRM vendors to consider before your next technology replacement cycle.

About The Omnipresence CXM


Omnipresence is a unified customer experience management (CXM) platform for healthcare and life sciences companies with CRM, omnichannel engagement, advanced analytics and AI capabilities in a single platform. The platform enables organizations to elevate and transform the experiences they can deliver to healthcare professionals, business partners, patients, and other stakeholders while modernizing disparate systems into a modern, digital ecosystem. The result of a strategic alliance between Indegene and Microsoft, Omnipresence unifies the power of Microsoft Azure and Microsoft AI together with Dynamics 365 and Power Platform business applications, and Microsoft Office 365 and Teams for intelligence-driven productivity, collaboration and customer experiences.

Contact Information

Omnipresence Technologies

600 Third Avenue, 2nd Floor, New York, NEW YORK, 10016

Useful Links


Request a demo


About us




Join the Conversation